ID: 206	RANK: 27	SCORE: 21.544014
<DOC>
<DOCNO> WSJ870805-0021 </DOCNO>
<HL> Business Brief:
Eli Lilly &amp; Co.</HL>
<DD> 08/05/87</DD>
<SO> WALL STREET JOURNAL (J)</SO>
<IN> LLY
PHARMACEUTICALS, HOSPITAL SUPPLIES, MANAGEMENT (PHA) </IN>
<TEXT>
   Eli Lilly &amp; Co., Indianapolis, said it licensed a new class of antibiotics called carbacephems from Kyowa Hakko Kogyo Co., of Japan. 
Terms of the agreement weren't disclosed. 
Lilly said the agreement gives it exclusive rights to market products of the new class, which are effective against a wide variety of pathogens, in any country except Japan. 
Under the agreement, Lilly will perform clinical testing on an oral form of the drug. 
Lilly is a pharmaceutical and agricultural-products concern. 
Kyowa Hakko markets drugs, chemicals, food and liquor. 

</TEXT>
</DOC>
